← Eichor
Study identifier: NCT06344650 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.

Condition: Acromegaly  ·  Sponsor: IRCCS San Raffaele

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Prospective observational clinical, molecular, translational study aimed at identifying the main determinants and predictive factors of fragility fracture risck in acromegaly patients

This description comes directly from the study's public registry record.

Talk to the study team

Stefano Frara, MD  ·  +390226435136  ·  frara.stefano@hsr.it

Gabriela Felipe, Nurse  ·  +390226435136  ·  felipe.gabriela@hsr.it

Always discuss trial participation with your own doctor first.

Locations (1)

Andrea GiustinaMilan, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06344650